KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Total Debt (2016 - 2025)

Resmed (RMD) has disclosed Total Debt for 16 consecutive years, with $259.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Debt rose 2523.72% year-over-year to $259.9 million, compared with a TTM value of $259.9 million through Dec 2025, up 2523.72%, and an annual FY2025 reading of $9.9 million, changed 0.0% over the prior year.
  • Total Debt was $259.9 million for Q4 2025 at Resmed, roughly flat from $259.9 million in the prior quarter.
  • Across five years, Total Debt topped out at $259.9 million in Q4 2025 and bottomed at $9.9 million in Q3 2024.
  • Average Total Debt over 5 years is $35.4 million, with a median of $9.9 million recorded in 2022.
  • The sharpest move saw Total Debt dropped 17.5% in 2022, then surged 2526.3% in 2025.
  • Year by year, Total Debt stood at $12.0 million in 2021, then fell by 17.5% to $9.9 million in 2022, then fell by 0.02% to $9.9 million in 2023, then increased by 0.08% to $9.9 million in 2024, then soared by 2523.72% to $259.9 million in 2025.
  • Business Quant data shows Total Debt for RMD at $259.9 million in Q4 2025, $259.9 million in Q3 2025, and $9.9 million in Q2 2025.